Jill Ruppenkamp

Johnson & Johnson (United States)

Papers

2

Total Citations

22

H-Index

2

About

Jill Ruppenkamp is a health economics and outcomes researcher whose work focuses on the clinical and economic value of advanced surgical technologies, particularly in orthopedics. Her primary research areas include robotic-assisted total knee arthroplasty (TKA), comparative effectiveness of surgical innovations, and real-world evidence generation to inform healthcare decision-making. Ruppenkamp’s major contributions center on evaluating the early clinical and economic outcomes of the VELYS Robotic-Assisted Solution (VRAS) compared to manual instrumentation for TKA, demonstrating that robotic assistance can improve surgical precision and reduce variability. Her most-cited paper, "Early Clinical and Economic Outcomes for the VELYS Robotic-Assisted Solution Compared with Manual Instrumentation for Total Knee Arthroplasty" (2024, 13 citations), provides critical evidence on the technology’s potential to enhance patient outcomes while managing costs. In a related study, "Are all robotic technologies created equal?" (2024, 9 citations), she systematically compares VRAS to other robotic systems, highlighting nuanced differences in design and performance. Ruppenkamp’s work is instrumental in guiding surgeons, hospital administrators, and payers as they evaluate the adoption of robotic-assisted platforms in joint replacement surgery.

Research Focus

Key Achievements

2
H-Index
2
Papers
22
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Early Clinical and Economic Outcomes for the VELYS Robotic-Assisted Solution Compared with Manual Instrumentation for Total Knee Arthroplasty
13 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago